Independent ASCs are declining after decades of sinking reimbursement rates and soaring operational costs have forced ASC ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company") today reported financial results for the fourth quarter and fiscal year 2024. Following the completion of the sale of INBRX-101 by Inhibrx, Inc.

In 2024, the operating model to deliver the highest quality of patient care was further optimized by enhancing financial returns, and creating value for shareholders; Fresenius Me ...

AMSURG, a national leader in ambulatory surgery center (ASC) management and healthcare services, today announced the introduction of its new company values, reinforcing its commitment to integrity, ...

Giving employees access to the best quality healthcare providers leads to better outcomes for them and their employers.

Invesco Growth Team maintains a constructive outlook for US equities in 2025. This view is informed by our expectation for 2.5-3% GDP growth, moderating inflation, rising corporate profits and less ...

The global ophthalmology PACS (Picture Archiving and Communication System) market is poised for substantial growth, projected ...

"Discover the latest trend in healthcare groups as they shift their ASC strategy towards partnerships with surgery centers and physician practices, rather than ...

The demand for medical office space in Western New York is rising, driven by an aging population and evolving health care ...

The Disposable Hospital Gowns Market plays a crucial role in healthcare, providing an essential barrier between patients and ...